Physician profile
Sameh Melouk
NPI 1841392487
$6,436.94
in general payments reported to CMS, 2019-2025
47 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $540 · 2021: $751 · 2022: $650 · 2023: $1,215 · 2024: $1,379 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,534 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,533.97 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $680.55 | 2019-2025 | |
| Janssen Biotech, INC. | $657.32 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $574.75 | 2019-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $530.22 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $499.04 | 2019-2025 | |
| Myovant Sciences INC. | $286.06 | 2021-2022 | |
| Teleflex LLC | $274.26 | 2021-2025 | Urolift, Barrigel |
| Endo Pharmaceuticals INC. | $252.76 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $192.95 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $191.68 | 2019-2021 | |
| 180 Medical, INC. | $149.77 | 2019-2024 | Gentlecath Glide |
| Boston Scientific Corporation | $147.30 | 2019-2025 | Flexiva, Spaceoar Vue System - 10ml, Axonics |
| Progenics Pharmaceuticals, INC. | $147.05 | 2023-2025 | Pylarify |
| Rochester Medical Corporation | $143.80 | 2020-2022 | |
| Axonics, INC. | $137.59 | 2021-2024 | Axonics, Bulkamid |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $126.64 | 2021-2025 | Jelmyto |
| Convatec INC. | $125.91 | 2023-2025 | |
| Tolmar, INC. | $119.81 | 2024-2025 | Eligard, Jatenzo |
| Dornier Medtech America, INC | $105.64 | 2024 | Dornier Medtech |
| Coloplast Corp | $88.51 | 2020-2024 | Altis |
| Allergan, INC. | $86.22 | 2020-2022 | |
| Blue Earth Diagnostics | $79.78 | 2019-2021 | |
| Amgen INC. | $76.91 | 2019-2022 | |
| Dentsply Ih Ab | $75.27 | 2023-2024 | Lofric, Lofric |
| Olympus America INC. | $72.56 | 2023-2024 | Itind System |
| Ferring Pharmaceuticals INC. | $62.66 | 2019-2025 | Adstiladrin |
| Novo Nordisk INC | $55.88 | 2024-2025 | Rivfloza |
| Merck Sharp & Dohme LLC | $52.89 | 2023-2024 | Welireg, Keytruda, Lynparza |
| Tempus Ai, INC | $49.20 | 2024-2025 | Xt Cdx |
| Telix Pharmaceuticals | $39.92 | 2024 | Illuccix |
| Novartis Pharmaceuticals Corporation | $34.22 | 2025 | |
| Agiliti Surgical, INC. | $32.97 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $25.40 | 2020 | |
| Myriad Genetic Laboratories, INC. | $23.22 | 2021 | |
| Immunitybio, INC. | $22.88 | 2024 | |
| Bard Access Systems, INC. | $22.60 | 2019 | |
| Urovant Sciences INC | $21.73 | 2022 | |
| Ethicon US, LLC | $21.11 | 2024 | Stratafix |
| Janssen Scientific Affairs, LLC | $20.30 | 2020 | |
| Bioprotect Medical, INC. | $18.25 | 2025 | Bioprotect Balloon Implant System |
| Sun Pharmaceutical Industries INC. | $18.09 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $17.76 | 2025 | Bard Urinary Drainage Bag |
| Biotissue Holdings INC. | $16.47 | 2024 | |
| Acell, INC. | $16.35 | 2020 | |
| Dentsply Ih INC. | $15.27 | 2020 | |
| Healthtronics Stone Solutions, LLC | $14.16 | 2019 | |
| Travere Therapeutics, INC. | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Melouk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.